A feasibility trial of preoperative radiosurgery for resectable brain metastases (PREOP-1)

被引:0
|
作者
Rogers, S. [1 ]
Schwyzer, L. [2 ]
Lomax, N. [1 ]
Alonso, S. [1 ]
Lazeroms, T. [1 ]
Schwenne, S. [1 ]
Silvia, G. [1 ]
Berkmann, S. [2 ]
Tortora, A. [2 ]
Marbacher, S. [2 ]
Schubert, G. [2 ]
Riesterer, O. [1 ]
机构
[1] Kantonsspital Aarau, Radiat Oncol Ctr KSA KSB, Aarau, Switzerland
[2] Kantonsspital Aarau, Dept Neurosurg, Aarau, Switzerland
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PD-0645
引用
收藏
页码:S537 / S538
页数:2
相关论文
共 50 条
  • [41] METIS: A phase III trial of radiosurgery with TTFields for 1-10 brain metastases from NSCLC
    Weinberg, U.
    Farber, O.
    Kinzel, A.
    Giladi, M.
    Bomzon, Z.
    Kirson, E.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2018, 194 : S116 - S116
  • [42] Feasibility, safety, and outcome of frameless image-guided robotic radiosurgery for brain metastases
    Muacevic, Alexander
    Kufeld, Markus
    Wowra, Berndt
    Kreth, Friedrich-Wilhelm
    Tonn, Joerg-Christian
    JOURNAL OF NEURO-ONCOLOGY, 2010, 97 (02) : 267 - 274
  • [43] Feasibility, safety, and outcome of frameless image-guided robotic radiosurgery for brain metastases
    Alexander Muacevic
    Markus Kufeld
    Berndt Wowra
    Friedrich-Wilhelm Kreth
    Jörg-Christian Tonn
    Journal of Neuro-Oncology, 2010, 97 : 267 - 274
  • [44] Radiosurgery for 1-4 brain metastases: Radiosurgery alone may be the preferred treatment
    Mazeron, Jean-Jacques
    BULLETIN DU CANCER, 2015, 102 (11) : 889 - 889
  • [45] Preoperative stereotactic radiosurgery for patients with 1-4 brain metastases: A single-arm phase 2 trial outcome analysis (NCT03398694)
    Agrawal, Namita
    Shireman, Jack M.
    Shiue, Kevin
    Kamer, Aaron
    Boyd, Lakeisha
    Zang, Yong
    Mukherjee, Neel
    Miller, James
    Kulwin, Charles
    Cohen-Gadol, Aaron
    Payner, Troy
    Lin, Chih-Ta
    Savage, Jesse J.
    Lane, Brandon
    Bohnstedt, Bradley
    Lautenschlaeger, Tim
    Saito, Naoyuki
    Shah, Mitesh
    Watson, Gordon
    Dey, Mahua
    NEURO-ONCOLOGY PRACTICE, 2024, 11 (05) : 593 - 603
  • [46] RANDOMIZED TRIAL OF RADIOSURGERY VERSUS SURGERY, EACH WITH WHOLE BRAIN RADIOTHERAPY, FOR SOLITARY BRAIN METASTASES
    Roos, D.
    RADIOTHERAPY AND ONCOLOGY, 2011, 99 : S369 - S369
  • [47] Safety And Efficacy Of Silibinin In Patients With Brain Metastases after Radiosurgery: Sustain Trial
    Desideri, I.
    Visani, L.
    Salvestrini, V.
    Mariotti, M.
    Banini, M.
    Angelini, L.
    Carnevale, M. G.
    Bonaparte, I.
    Zisca, L.
    Detti, B.
    Greto, D.
    Meattini, I.
    Livi, L.
    RADIOTHERAPY AND ONCOLOGY, 2022, 170 : S965 - S966
  • [48] A phase I trial of concurrent sorafenib and stereotactic radiosurgery for patients with brain metastases
    Kyle Arneson
    Joshua Mondschein
    Mark Stavas
    Anthony J. Cmelak
    Albert Attia
    Leora Horn
    Kenneth Niermann
    Igor Puzanov
    A. Bapsi Chakravarthy
    Fen Xia
    Journal of Neuro-Oncology, 2017, 133 : 435 - 442
  • [49] A phase I trial of concurrent sorafenib and stereotactic radiosurgery for patients with brain metastases
    Arneson, Kyle
    Mondschein, Joshua
    Stavas, Mark
    Cmelak, Anthony J.
    Attia, Albert
    Horn, Leora
    Niermann, Kenneth
    Puzanov, Igor
    Chakravarthy, A. Bapsi
    Xia, Fen
    JOURNAL OF NEURO-ONCOLOGY, 2017, 133 (02) : 435 - 442
  • [50] Stereotactic Radiosurgery Versus Stereotactic Radiosurgery and Whole Brain Radiation Therapy for 1-3 Brain Metastases
    Lester-Coll, N.
    Dosoretz, A. P.
    Yu, J. B.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S177 - S177